May 15, 2026 Experience Oruka Therapeutics collaboration with Halozyme We advised Oruka Therapeutics on the transaction
May 15, 2026 Experience Esentia $600 million revolving credit facility We advised Esentia on the transaction
May 15, 2026 Experience Bombardier $500 million senior notes offering We advised the initial purchasers on the notes offering
May 15, 2026 Experience PayPal Holdings $2 billion notes offering We advised the underwriters on the offering
May 14, 2026 Experience BBVA $2.25 billion contingent convertible securities and senior notes offerings We advised BBVA on its offerings
May 14, 2026 Experience Purdue Pharma completes chapter 11 restructuring We advised Purdue in connection with its nearly seven year-long chapter 11 restructuring
May 14, 2026 Experience Bolivia $1 billion sovereign bond issuance We advised Bolivia on the offering
May 14, 2026 Experience First Eagle Holdings $575 million debut senior secured notes offering We advised the initial purchasers on the high-yield notes offering
May 14, 2026 Experience GH Research $200 million at-the-market offering We advised GH Research on the establishment of the at-the-market program